Skip to main content
Log in

Hypophyseal-pituitary-adrenal axis in autoimmune and rheumatic diseases

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

This article discusses the effects of sex steroids and anterior pituitary hormones on the immune system. Data from clinical and experimental studies on the effects of CRH, FSH, LH, and prolactin are reviewed. This is followed by a summary of results from our studies on the effects of FSH, LH, and prolactin on PBMC, CD4+ cells, and CD8+ cells in vitro.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hochberg MC. Epidemiology of rheumatic diseases. Rheum Dis Clinics N Am 1990;16(3):499–789.

    Google Scholar 

  2. Beeson PB. Age and sex association of 40 autoimmune diseases. Amer J Med 1994;96:457–462.

    Article  PubMed  CAS  Google Scholar 

  3. Doniach D, Roitt IM. Autoimmune Thyroid Disease in Textbook of Immunopathology Vol. II, Misher PA, Muller-Eberhard HJ (ed.): Grune and Stratton, New York, NY, 1976, 715.

    Google Scholar 

  4. Lahita RA. Sex steroids and rheumatic diseases. Arthritis Rheum 1985;28:121–126.

    Article  PubMed  CAS  Google Scholar 

  5. Goemaere S, Ackerman C, Goethals K, et al. Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol 1990;17:1620–1622.

    PubMed  CAS  Google Scholar 

  6. Ostersen M, Aune B, Husby G. Effects of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 1983; 12:69–72.

    Article  Google Scholar 

  7. Zulian FM, Schumacher HR, Calorc A, Goldsmith DG, and Athreya BH. Turner syndrome and juvenile arthritis. Clin Exp Rheumatol 1998;16:489–494.

    PubMed  CAS  Google Scholar 

  8. Stern R, Fishman J, Bursman H, Kunkel HG. Systemic lupus erythematosus associated with Klinefelter syndrome. Arthritis Rheum 1977;20:8–22.

    Article  Google Scholar 

  9. Lahita SG. Sex steroids and autoimmunity. in: Weissman G (ed.): Advances Inflammation Research, vol 8, Raven, NY, 1984, 143,144.

    Google Scholar 

  10. Roubinian J, Talal N, Siiteri PK, Sadakian JA. Sex hormone modulation of autoimmunity in NZB/ NZW mice. Arthritis Rheum 1979;22:1162–1169.

    PubMed  CAS  Google Scholar 

  11. Brick JC, Wilson DA, Walker SA. Hormonal modulation of responses to thymus-independent and thymus-dependent antigens in autoimmune NZB/NZW mice. J Immunol 1985; 134:3603–3608.

    Google Scholar 

  12. Ahmed AM, Dauphinee J, Talal N. Effects of short term administration of sex hormones on normal and autoimmune mice. J Immunol 1985;134:204–210.

    CAS  Google Scholar 

  13. Sthoegher ZM, Chirozzi M, Lahita RG. Regulation of the immune response by sex hormones I. Effects of estradiol and testosterone on pokeweed mitogen induced human B cell differentiation. J Immunol 1988; 141:91–98.

    Google Scholar 

  14. Chrousos GP. The hypothalamicpituitary adrenal axis and immunemediated inflammation. N Engl J Med 1995;332:1351–1362.

    Article  PubMed  CAS  Google Scholar 

  15. Sternberg EM, Hill JM, Chrousos GP, et al. Inflammatory mediator induced hypothalamic-pituitary adrenal axis activation is defective in stretococcal cell wall arthritis susceptible Lewis rats. Proc Natl Acad Sci USA 1989;86:2374–2378.

    Article  PubMed  CAS  Google Scholar 

  16. Sternberg EM, Scott-Young W, Bernadini R, et al. A central nervous system defect in the biosynthesis of cortocotropin-relelasing hormone is associated with susceptibility to streptococcal cell well induced arthritis in Lewis rats. Proc Natl Acad Sci USA 1989;86:4771–4775.

    Article  PubMed  CAS  Google Scholar 

  17. Neeck G, Federlin K, Graef V, et al. Adrenal secretion of cortisol in patients with rheumaoid arthritis. J Rheumatol 1990; 17:24–29.

    PubMed  CAS  Google Scholar 

  18. Chikanza I, Petrou P, Kingsley G, et al. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis and Rheum 1992;35:1281–1288.

    CAS  Google Scholar 

  19. Kavelaars A, Wuffraat N, Kuis W, Heiznen C. Decreased ability of the hypothalamic pituitary adrenal axis in children with polyarticular Juvenile Chronic Arthritis Arthritis Rheum 1996;39(s):S55.

    Google Scholar 

  20. Baerwald CGO, Panayi GS, Lanchburg JS. Corticosporin releasing hormone promotor region polymorphism in rheumatoid arthritis. J Rheumatol 1997;24:215–216.

    PubMed  CAS  Google Scholar 

  21. Wilson J, Foster D. Textbook of Endocrinology, 7th Ed. W. B. Saunders, Philadelphia, 1985.

    Google Scholar 

  22. Boneface JJ, Reichert LEJ. Evidence for a novel thioredoxin-like catalytic property of gonadotropic hormone. Science 1990;247:61–74.

    Article  Google Scholar 

  23. Wakasagi N, Tagaya Y, Wakasugi H, et al. Adult T cell leukemia-derived growth factor/thioredoxin, produced by both humanT-lymphotropic virus type-I and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci USA 1990; 87:8282–8286.

    Article  Google Scholar 

  24. Borth W, Scheer B, Urbansky A, et al. Binding of IL-1 B to a alphamacroglobulin and release by thiorexdoxin. J Immunol 1990; 145:3747–3754.

    PubMed  CAS  Google Scholar 

  25. Deiss LP, Kuchi A. A genetic tool used to identify thioredoxin as a mediator of growth inhibitory signal. Science 1991;252:117–120.

    Article  PubMed  CAS  Google Scholar 

  26. Woolman EE, d’Auriol L, Rimsky L, et al. Cloning and expression of a cDNA for human thioredoxin. J Biol Chem 1988;263:15,506–15,512.

    Google Scholar 

  27. Reichert LJ, Dattatreyamurty B. The follicle-stimulating hormone (FSH) receptor in testis: interaction with FSH, mechanism of signal transduction and properties of the purified receptor. Biol Reprod 1989;40:13–26.

    Article  PubMed  CAS  Google Scholar 

  28. Costa O, Bouthet C, Swavage P, et al. Age dependent LH and FSH effect on the proliferation of women’s peripheral blood lymphocytes in vitro. Int J Immunopharmacol 1990;12:821–829.

    Article  PubMed  CAS  Google Scholar 

  29. Rouabhia M, Deschaux PA, Othemen O. Contribution a l’etude de la neuroimmunomodulatin de la response immunnitaire par le systeme endocrinien: effet de l’hormone luteinasante (LH) sur la response proliferative des lymphocytes. Jpn J Med Sci Biol 1987;40:147–151.

    PubMed  CAS  Google Scholar 

  30. Cutolo M, Ballerari E, Giusti M, et al. Sex hormone status of male patients with rheumatoid arthritis. Evidence of low serum concentrations of testosterone at baseline and after human chronic gonadotropin stimulation. Arthritis Rheum 1988;31:1314–1317.

    Article  PubMed  CAS  Google Scholar 

  31. Spector TD, Perry LA, Tubb, et al. Low free testosterone levels in rheumatoid arthritis. Ann Rheum Dis 1988;47:65–68.

    PubMed  CAS  Google Scholar 

  32. Gordon D, Beastall GH, Thomson JA, Sturrock RD. Androgenic status and sexual function in males with rheumatoid arthritis and ankylosing spondylitis. Quart. J Med 1986:60:671–679.

    PubMed  CAS  Google Scholar 

  33. Martens HF, Sheets PK, Tenover JS, et al. Primary testicular failure in male rheumatoid arthritis patients. Arthritis Rheum 1991;S21.

  34. Stahl NI, Decker J. Androgenic status of males with systemic lupus erythematosus. Arthritis Rheum 1978:21:665–668.

    Article  PubMed  CAS  Google Scholar 

  35. Jungers P, Kuttenn F, Liote F, et al. Hormonal modulation of systemic lupus erythematosus. Arthritis Rheum 1985;28:1243–1250.

    Article  PubMed  CAS  Google Scholar 

  36. Lavelle C, Loyo E, Paniagua R, et al Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 1987; 14:268–272.

    Google Scholar 

  37. Kooijman R, Hooghe-Peters EL, Hooghe R. Prolactin, growth hormone and insulin-like growth factor-1 in the immune system Adv Immunol 1996;63:377–454.

    Article  PubMed  CAS  Google Scholar 

  38. Berczi I, Nagy E. A possible role of prolactin in adjuvant arthritis. Arthritis Rheum 1982;25:591–594.

    Article  PubMed  CAS  Google Scholar 

  39. Whyte A, Williams RO. Bromocriptine suppresses postpartum exacerbation of collagen induced arthritis. Arthritis Rheum 1988; 31:927–928.

    Article  PubMed  CAS  Google Scholar 

  40. McMurray R, Keisler D, Kaunckel SK, et al. Prolactin influences autoimmune disease activity in the female B/W mice. J Immunol 1991:147:3780–3787.

    PubMed  CAS  Google Scholar 

  41. McMurray R, Keisler D, Izui S, Walker SE. Hyperprolactinemia in male NZB1 N2W (B/W) F1 mice: Accelerated autoimmune disease with normal circulating testosterone. Clin Immunol Immunopathol 1994:71:338–343.

    Article  PubMed  CAS  Google Scholar 

  42. Jara-Quezada L, Graef A, Lavelle C. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematopsus. J Rheumatol 1991; 18:345–353.

    Google Scholar 

  43. Jara LJ, Gomez-Sanchez C, Silveria LH, et al Hyproprolactinemia in SLE: association with disease activity Am J Med Sci 1992;303:222–226.

    Article  PubMed  CAS  Google Scholar 

  44. Nagy E, Chalmers IM, Fletcher Baregan D, Friesen HG, Berczi I. Prolactin deficiency in rheumatoid arthritis. J Rheumatol 1991:18:1662–1668

    PubMed  CAS  Google Scholar 

  45. McMurray RW, Allen SH, Pepmueller PH, et al Elevated serum prolactin levels in chidren with JRA and ANA seropositivity J Rheumol 1995:22:1577–1580.

    CAS  Google Scholar 

  46. McMurray RW, Weidensaul D, Allen SH, Walker SE. Efficacy of bromocriptine in an open label therapeutic trial for SLE. J Rheumatol 1995;22:2084–2091.

    PubMed  CAS  Google Scholar 

  47. Bravo G, Zazueta B, Lavalle C. An acute remission of Reiter’s syndrome in patients treated with bromocriptine. J Rheumatol 1992;19:247–250.

    Google Scholar 

  48. Vidaller A, Llorante L, Larrea F, et al. Immune dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment. Clin Immunol Immunopathol 1986:38:337–343.

    Article  PubMed  CAS  Google Scholar 

  49. Hiestand PC, Mekler P, Nordmann R. et al. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc Natl Acad Sci USA 1986:83:2599–2603.

    Article  PubMed  CAS  Google Scholar 

  50. Russell DH, Kibler R, Matrisian L, Larson DF, Poulos B, Magun BE Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol 1985; 134:3027–3031.

    PubMed  CAS  Google Scholar 

  51. Gagnerault MC, Touraine P, Sarno W, et al. Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J. Immunol 1993;150: 5673–5681.

    PubMed  CAS  Google Scholar 

  52. Brennan P, Ollier B, Worthington J, et al. Are both genetic and reproductive association with rheumatoid arthritis linked to prolactin? Lancet 1996;348:106–109.

    Article  PubMed  CAS  Google Scholar 

  53. Dunkel L, Alfthan H, Stenman U-H, Tapanainen P, Perheentupa J, Pulsatile secretion of LH and FSH in prepubertal and early pubertal boys revealed by ultrasensitive, time resolved immunofluorometric assays. Ped Res 1990;27(3):215–219.

    Article  CAS  Google Scholar 

  54. Loriaux DL. The pathophysiology of precocous puberty. Hospital Practice, Dec 15, 1989, p 55–61.

  55. Athreya BH, Rafferty J, Lahita RG, Singh GS. Adenohypophyseal and sex hormones in pediatric reheumatoid disease. J Rheumatol 1993;20 (4):725–730.

    PubMed  CAS  Google Scholar 

  56. Athreya BH, Pletcher J, Zulian F, et al. Subset specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro, Clin Immunol Immunopathol 1993;66(3):201–211.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Athreya, B.H., Rettig, P. & Williams, W.V. Hypophyseal-pituitary-adrenal axis in autoimmune and rheumatic diseases. Immunol Res 18, 93–102 (1998). https://doi.org/10.1007/BF02788752

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02788752

Key Words

Navigation